NovoCure Limited (NVCR)

NovoCure Revenue

NovoCure had revenue of $183.58M in the quarter ending June 30, 2026, with 15.60% growth. This brings the company's total for the last twelve months to $699.19M, up 10.95% year-over-year. In the year 2025, NovoCure had annual revenue of $655.35M with 8.28% growth. That makes NovoCure the 9,362nd largest company in the world by revenue and 2,049th in the United States.

• Revenue (ttm): $699.19M
• Revenue Growth: +10.95%
• P/S Ratio: 2.40
• Revenue / Employee: $435,634
• Employees: 1,605
• Market Cap: 1.68B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 385.63M 58.8%
• Germany 79.41M 12.1%
• France 76.19M 11.6%
• Other International Markets 56.90M 8.7%
• Japan 37.79M 5.8%
• Greater China 19.44M 3.0%

Fiscal year ended Dec 31, 2025 See the full NovoCure breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	655.35M	50.13M	8.28%
Dec 31, 2024	605.22M	95.88M	18.82%
Dec 31, 2023	509.34M	-28.50M	-5.30%
Dec 31, 2022	537.84M	2.81M	0.53%
Dec 31, 2021	535.03M	40.67M	8.23%
Dec 31, 2020	494.37M	143.05M	40.72%
Dec 31, 2019	351.32M	103.25M	41.62%
Dec 31, 2018	248.07M	71.04M	40.13%
Dec 31, 2017	177.03M	94.14M	113.57%
Dec 31, 2016	82.89M	49.80M	150.52%
Dec 31, 2015	33.09M	17.60M	113.60%
Dec 31, 2014	15.49M	5.13M	49.53%
Dec 31, 2013	10.36M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 23, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Oct 22, 2026

Data Sources Report a data error